Unraveling the Effect of Breast Cancer Patients’ Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles

Abstract

The formation of protein corona (PC) around nanoparticles (NPs) has been reported inside biological conditions. This effect can alter delivery capacity toward the targeted tissues. Here, we synthesized folic acid-modified chitosan NPs (FA-CS NPs) using different concentrations of folic acid (5, 10, and 20%). FA-CS NPs were exposed to plasmas of breast cancer patients and healthy donors to evaluate the possibility of PC formation. We also monitored uptake efficiency in in vitro conditions after incubation with human breast cancer cell line MDA-MB-231 and monocyte/macrophage-like Raw264.7 cells. Data showed that the formation of PC around FA-CS NPs can change physicochemical properties coincided with the rise in NP size and negative surface charge. SDS-PAGE electrophoresis revealed differences in the type and content rate of plasma proteins attached to NP surface in a personalized manner. Based on MTT data, the formation of PC around NPs did not exert cytotoxic effects on MDA-MB-231 cells while this phenomenon reduced uptake rate. Fluorescence imaging and flow cytometry analyses revealed reduced cellular internalization rate in NPs exposed to patients' plasma compared to the control group. In contrast to breast MDA-MB-231 cells, Raw264.7 cells efficiently adsorbed the bare and PC-coated NPs from both sources, indicating the involvement of ligand−receptor-dependent and independent cellular engulfment. These data showed that the PC formed on the FA-CS NPs is entirely different in breast cancer patients and healthy counterparts. PC derived from patients' plasma almost abolishes the targeting efficiency of FA-CS NPs even in different mechanisms, while this behavior was not shown in the control group. Surprisingly, Raw264.7 cells strongly adsorbed the PC-coated NPs, especially when these particles were in the presence of patients' sera. It is strongly suggested that the formation of PC around can affect delivering capacity of FA-CS NPs to cancer cells. It seems that the PC-coated FA-CS NPs can be used as an efficient delivery strategy for the transfer of specific biomolecules in immune system disorders.

Recent Advances in Chitosan and its Derivatives in Cancer Treatment

“…The conjugates of some anticancer drugs with chitosan and its derivatives selectively accumulate in tumors and prolong retention time in the blood circulation, thus show excellent anticancer effects with much milder adverse effects than that of the original drug due to cancer site-specific distribution and sustained release characteristics. Based on the cationic properties of chitosan, ionic cross-linked chitosan nanoparticles were prepared by electrostatic interaction, in which the amino group on the main chain interacts with polyanionic cross-linking agents such as tripolyphosphate (TPP), CaCl2, Na2SO4 and so on ( Babu and Ramesh, 2017 ; Nemati et al, 2021 ). The process of ionically cross-linking requires more simple and mild preparation conditions with no toxic reagents, which is completely different from the chemical cross-linking.…”

Chitosan as an Outstanding Polysaccharide Improving Health-Commodities of Humans and Environmental Protection

“…Thus, at pH between 6.5 and 8, the chitosan chains show ζ = 0 or near to this value, and therefore electrostatic interactions are limited [ 9 , 10 , 11 ]. However, the chitosan backbone can be modified to adjust its physicochemical properties (e.g., water solubility) and control its chemical interaction according to the application requirements [ 12 , 13 , 14 ], boosting the performance. Indeed, unlike chitin and cellulose, the presence of amino groups allows to perform chemical reactions specific to this reactive site.…”

Folic Acid–Modified Long-Circulating Liposomes Loaded with Sulfasalazine For Targeted Induction of Ferroptosis in Melanoma

“…While our study establishes the promising potential of FA-SSZ-Lips, it is imperative to acknowledge that the formation of protein coronas around nanoparticles may potentially influence their targeting ability. Therefore, controlling the protein corona represents a critical factor in nanoparticle targeting research. − …”